학술논문
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation—Immune signature correlates with response
Document Type
Article
Author
Apostolova, P.; Burk, A.-C.; Wehr, C.; Maas-Bauer, K.; Melchinger, W.; Haring, E.; Hoefflin, R.; Shoumariyeh, K.; Hupfer, V.; Lauer, E.M.; Duquesne, S.; Lowinus, T.; Weiss, M.; Böke, C.; Pfeifer, D.; Marks, R.; Bertz, H.; Wäsch, R.; Duyster, J.; Finke, J.; Zeiser, R.; Kreutmair, S.; Boerries, M.; Unger, S.; Gonzalo Núñez, N.; Alberti, C.; da Costa Pereira, S.; Merten, C.H.; Power, L.; Becher, B.; Toffalori, C.; Punta, M.; Vago, L.; Ihorst, G.; Gentner, B.; Andrieux, G.
Source
In: British Journal of Haematology . (British Journal of Haematology, October 2023, 203(2):264-281)
Subject
Language
English
ISSN
13652141
00071048
00071048